Tetrac
CAS: 67-30-1
Ref. TM-T36715
10mg | 46.00 € | ||
25mg | 85.00 € | ||
50mg | 114.00 € | ||
100mg | 168.00 € | ||
500mg | 407.00 € | ||
1ml*10 (DMSO) | 50.00 € |
Product Information
- Tetraiodothyroacetic acid, 3,3',5,5'-Tetraiodothyroacetic acid
- 3,3′,5,5′-Tetraiodothyroacetic acid
- 3,5,3′,5′-Tetraiodothyroacetic acid
- 3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid
- 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetic acid
- 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid
- Acetic acid, (4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)- (8CI)
- Acetic acid, [4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-
- Acide 3,5,3',5'-tetraiodothyroacetique
- Acide 3,5,3',5'-tetraiodothyroacetique [French]
- See more synonyms
- Benzeneacetic acid, 3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)-
- Benzeneacetic acid, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-
- Tetraiodothyroacetic acid
- Thyroacetic acid, 3,3',5,5'-tetraiodo-
- Thyroacetic acid, 3,3′,5,5′-tetraiodo-
Tetrac (Tetraiodothyroacetic acid) is a derivative of L-thyroxine (T4), a thyroxine integrin receptor antagonist.Tetrac induces antiproliferation by blocking EGFR-mediated cell signaling in colorectal cancer cells.Tetrac blocks the effects of T4 and 3,5,3'-triiodo-L-thyronine (T3) on the cell-surface thyroxine integrin αvβ3 receptors.Tetra has anti-angiogenic, anti-tumor activity and pro-apoptotic activity.
Chemical properties
Technical inquiry about: TM-T36715 Tetrac
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.